1 |
McDevitt, J. T., Gurst, A. H. and Chen, Y. : Accuracy of tablet splitting. Pharmacotherapy 18, 193 (1998).
|
2 |
Zhan, C., Smith, S. R., Keyes, M. A., Hicks, R. W., Cousins, D. D. and Clancy, C. M. : How useful are voluntary medication error reports? The case of warfarin-related medication errors. Jt. Comm. J. Qual. Patient. Saf. 34, 36 (2008).
DOI
|
3 |
Fiumara, K. and Goldhaber, S. Z. : A patient's guide to taking coumadin/warfarin. Circulation 119, e220 (2009).
DOI
|
4 |
BIT Druginfo http://www.druginfo.co.kr/. Accessed on October 27 (2013).
|
5 |
Chou, C. Y., Hsu, C. C., Chiang, S. C., Ho, C. C., Chou, C. L., Wu, M. S., Chang, Y. L., Tsai, H. Y., Chen, T. J. and Chou, Y. C. : Association between physician specialty and risk of prescribing inappropriate pill splitting. PLoS One. 29, e70113 (2013).
|
6 |
National Health Insurance Service. Website http://stat.kosis.kr/ Accessed on October 20 (2013).
|
7 |
Levy, G. : What are narrow therapeutic index drugs? Clin. Pharmacol. Ther. 63, 501 (1998).
DOI
|
8 |
Benet, L. Z. and Goyan, J. E. : Bioeguivalence and narrow therapeutic index drugs. Pharmacotherapy 15, 433 (1995).
|
9 |
Wittkowsky, A. K. : Generic warfarin: Implications for patient care. Pharmacotherapy 17, 640 (1997).
|
10 |
Budnitz, D. S., Shehab, N., Kegler, S. R. and Richards, C. L. : Medication use leading to emergency department visits for adverse drug events in older adults. Ann. Intern. Med. 147, 755 (2007).
DOI
ScienceOn
|
11 |
Blix, H. S., Viktil, K. K., Moger, T. A. and Reikvam, A. : Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients. Pharmacy Practice (Internet) 8, 50 (2010).
|
12 |
Doan, J., Zakrzewski-Jakubiak, H., Roy, J. and Turgeon, J. : Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Tannenbaum CAnn Pharmacother. 47, 324 (2013).
DOI
|
13 |
Hines, L. E. and Murphy, J. E. : Potentially harmful drug-drug interactions in the elderly: a review. Am. J. Geriatr. Pharmacother. 9, 364 (2011).
DOI
|
14 |
Clinical pharmacology. http://www.clinicalpharmacology. Accessed on October 20 (2013).
|
15 |
Hylek, E. M. : Oral anticoagulants. Pharmacologic issues for use in the elderly. Clin. Geriatr. Med. 17, 1 (2001).
DOI
|
16 |
Miura, T., Kojima, R., Sugiura, Y., Mizutani, M., Takatsu, F. and Suzuki, Y. : Effect of aging on the incidence of digoxin toxicity. Ann. Pharmacother. 34, 427 (2000).
DOI
|
17 |
Vooren, L. V., Spiegeleer, B. D., Thonissen, T., Joye, P., Durme, J. V. and Slegers, G. : Statistical analysis of tablet breakability methods. J. Pharm. Pharmaceut. Sci. 5, 190 (2002).
|
18 |
Tahaineh, L. M. and Gharaibeh, S. F. : Tablet splitting and weight uniformity of half-tablets of 4 medications in pharmacy practice. J. Pharm. Pract. 25, 471 (2012).
DOI
|
19 |
Rosenberg, J. M., Nathan, J. P. and Plakogiannis, F. : Weight variability of pharmacist-dispensed split tablets. J. Am. Pharm. Assoc. 42, 200 (2002).
DOI
|
20 |
Choonara, I. A., Malia, R. G., Haynes, B. P., Hay, C. R., Cholerton, S., Breckenridge, A. M., Preston, F. E. and Park, B. K. : The relationship between inhibition of vitamin K1 2,3- epoxide reductase and reduction of clotting factor activity with warfarin. Br. J. Clin. Pharmacol. 25, 1 (1988).
DOI
|
21 |
Nelsestuen, G. L. : Role of gamma-carboxyglutamic acid: an unusual transition required for calcium-dependent binding of prothrombin to phospholipid. J. Biol. Chem. 251, 5648 (1976).
|
22 |
Malhotra, O. P., Nesheim, M. E. and Mann, K. G. : The kinetics of activation of normal and gamma carboxy glutamic acid deficient prothrombins. J. Biol. Chem. 260, 279 (1985).
|
23 |
Kirley, K., Qato, D. M., Kornfield, R., Stafford, R. S. and Alexander, G. C. : National Trends in Oral Anticoagulant Use in the United States, 2007 to 2011. Circ Cardiovasc Qual Outcomes. 5, 615 (2012).
DOI
|